Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
AssayType

Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

CHEMBL1893324 209060 24 None 1 3 Human 10.7 pEC50 = 10.7 Functional
Agonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAgonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1021/acs.jmedchem.0c01396
168299476 192746 0 None -1 3 Human 10.5 pEC50 = 10.5 Functional
Agonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAgonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL 4660 165 74 67 -19.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O 10.1021/acs.jmedchem.0c01396
CHEMBL5220770 192746 0 None -1 3 Human 10.5 pEC50 = 10.5 Functional
Agonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAgonist activity at VPAC1 in human SH-SY5Y cells assessed as cAMP accumulation incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL 4660 165 74 67 -19.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O 10.1021/acs.jmedchem.0c01396
CHEMBL4294827 213532 0 None -2 2 Human 9.7 pEC50 = 9.7 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H]1CNC[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(C)=O)C(C)C)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)NC(CC(N)=O)CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O nan
CHEMBL4280734 213409 0 None 223 2 Human 9.5 pEC50 = 9.5 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
2263 257 0 None -4 3 Human 9.2 pEC50 = 9.2 Functional
Activity at human VPAC1 receptor in CHO cells by measuring cAMP accumulationActivity at human VPAC1 receptor in CHO cells by measuring cAMP accumulation
ChEMBL None None None None 10.1021/jm0609059
44566111 257 0 None -4 3 Human 9.2 pEC50 = 9.2 Functional
Activity at human VPAC1 receptor in CHO cells by measuring cAMP accumulationActivity at human VPAC1 receptor in CHO cells by measuring cAMP accumulation
ChEMBL None None None None 10.1021/jm0609059
CHEMBL219499 257 0 None -4 3 Human 9.2 pEC50 = 9.2 Functional
Activity at human VPAC1 receptor in CHO cells by measuring cAMP accumulationActivity at human VPAC1 receptor in CHO cells by measuring cAMP accumulation
ChEMBL None None None None 10.1021/jm0609059
CHEMBL4295255 213535 0 None - 1 Human 8.0 pEC50 = 8.0 Functional
Induction of VIPR1 receptor internalization in CHOK1 cells expressing human VIPR1 by beta-galactosidase reporter gene assayInduction of VIPR1 receptor internalization in CHOK1 cells expressing human VIPR1 by beta-galactosidase reporter gene assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4282016 213428 0 None -204 2 Human 6.9 pEC50 = 6.9 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O nan
CHEMBL4277870 213381 0 None -1659 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4282364 213431 0 None -1071 2 Human 5.9 pEC50 = 5.9 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NC(CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)NC(CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4287451 213469 0 None -426 2 Human 5.8 pEC50 = 5.8 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NC(CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NC(CCC(N)=O)CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4295255 213535 0 None - 1 Human 8.7 pEC50 = 8.7 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4277441 213371 0 None -1202 2 Human 6.7 pEC50 = 6.7 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4286419 213463 0 None -234 2 Human 6.5 pEC50 = 6.5 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NC(CC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4281814 213424 0 None 58 2 Human 8.4 pEC50 = 8.4 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4290756 213501 0 None - 1 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H]1CCC[C@@H]1C(=O)NC(CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)Cc1ccc(O)cc1)[C@@H](C)O nan
CHEMBL4277709 213377 0 None 870 2 Human 8.3 pEC50 = 8.3 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4277799 213380 0 None -977 2 Human 6.3 pEC50 = 6.3 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NC(C)(C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4284839 213448 0 None 11 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)CC(CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4281905 213426 0 None -1 2 Human 7.2 pEC50 = 7.2 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4291903 213511 0 None -660 2 Human 6.1 pEC50 = 6.1 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H]1CCC[C@@H]1C(=O)NC(CC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)NC(CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)CC(C)C)[C@@H](C)O)Cc1ccc(O)cc1)[C@@H](C)O nan
CHEMBL4282941 213434 0 None - 1 Human 7.1 pEC50 = 7.1 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4294843 213533 0 None 11 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)NC(CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)CC(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4291119 213506 0 None -22 2 Human 8.0 pEC50 = 8.0 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NC(CCCCN)CC(=O)NCC(=O)NCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(C)C nan
CHEMBL4277783 213379 0 None -1 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)CC(CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CC(NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CC(CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CC(NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)CC(NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CC(CC(=O)O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)C(C)O)C(C)O)C(C)C)C(=O)NC(CC(=O)N[C@@H](CC(N)=O)C(=O)O)CC(C)C nan
CHEMBL4284961 213451 0 None -9 2 Human 6.0 pEC50 = 6.0 Functional
Agonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assayAgonist activity at human VIPR1 expressed in CHOK1 cells assessed as intracellular cAMP accumulation after 60 mins by PathHunter assay
ChEMBL None None None CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H]1CNC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CC(Cc1ccc(O)cc1)NC(=O)CC(CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]1CCC[C@@H]1NC(=O)[C@@H](N)Cc1cnc[nH]1)[C@@H](C)O)[C@@H](C)O)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O nan
57395756 71213 0 None - 1 Rat 7.0 pIC50 = 7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 316 3 1 1 5.9 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(Cl)c2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956426 71213 0 None - 1 Rat 7.0 pIC50 = 7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 316 3 1 1 5.9 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(Cl)c2)c1CO 10.1016/j.bmcl.2012.01.082
57399212 71221 0 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1ccccc1CCC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956434 71221 0 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1ccccc1CCC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
11570626 2550 46 None -707 8 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counterAntagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counter
ChEMBL 587 9 2 5 7.5 COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl 10.1021/jm300579z
9135 2550 46 None -707 8 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counterAntagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counter
ChEMBL 587 9 2 5 7.5 COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl 10.1021/jm300579z
CHEMBL1933349 2550 46 None -707 8 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counterAntagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counter
ChEMBL 587 9 2 5 7.5 COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl 10.1021/jm300579z
DB12044 2550 46 None -707 8 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counterAntagonist activity at human VPAC1 expressed in HT-29 cells assessed as inhibition of glucagon-induced cAMP accumulation preincubated for 30 mins prior to glucagon challenge measured after 30 mins post glucagon challenge by liquid scintillation counter
ChEMBL 587 9 2 5 7.5 COc1ccc2c(c1)ccc(c2)c1cc(nn1[C@H](c1ccc(cc1)C(=O)NCCC(=O)O)C)c1cc(Cl)cc(c1)Cl 10.1021/jm300579z
168298339 192709 0 None -33 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at VPAC1 in human SH-SY5Y cells assessed as inhibition of PACAP38-induced cAMP accumulation pre-incubated for 30 mins followed by agonist addition and measured after 75 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAntagonist activity at VPAC1 in human SH-SY5Y cells assessed as inhibition of PACAP38-induced cAMP accumulation pre-incubated for 30 mins followed by agonist addition and measured after 75 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL 4137 147 67 59 -16.2 CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](CCS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C 10.1021/acs.jmedchem.0c01396
CHEMBL5219662 192709 0 None -33 3 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at VPAC1 in human SH-SY5Y cells assessed as inhibition of PACAP38-induced cAMP accumulation pre-incubated for 30 mins followed by agonist addition and measured after 75 mins by Eu-cAMP tracer based LANCE ultra cAMP assayAntagonist activity at VPAC1 in human SH-SY5Y cells assessed as inhibition of PACAP38-induced cAMP accumulation pre-incubated for 30 mins followed by agonist addition and measured after 75 mins by Eu-cAMP tracer based LANCE ultra cAMP assay
ChEMBL 4137 147 67 59 -16.2 CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](CCS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccccc1)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C)C(C)C 10.1021/acs.jmedchem.0c01396
57395755 71212 0 None - 1 Rat 6.9 pIC50 = 6.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 332 3 1 1 6.4 CC(C)c1cc(C(C)(C)C)cc(-c2ccc3ccccc3c2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956425 71212 0 None - 1 Rat 6.9 pIC50 = 6.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 332 3 1 1 6.4 CC(C)c1cc(C(C)(C)C)cc(-c2ccc3ccccc3c2)c1CO 10.1016/j.bmcl.2012.01.082
19220887 71226 2 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 344 4 1 3 4.7 N#Cc1c(NC(=O)CCc2ccc(Cl)cc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956439 71226 2 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 344 4 1 3 4.7 N#Cc1c(NC(=O)CCc2ccc(Cl)cc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
810647 71215 49 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 234 2 1 3 2.8 CCC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956428 71215 49 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 234 2 1 3 2.8 CCC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
57402730 71230 0 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 336 2 1 3 4.2 N#Cc1c(NC(=O)C2CCc3ccccc3C2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956443 71230 0 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 336 2 1 3 4.2 N#Cc1c(NC(=O)C2CCc3ccccc3C2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57399163 71201 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1 10.1016/j.bmcl.2012.01.082
CHEMBL1956414 71201 0 None - 1 Rat 5.9 pIC50 = 5.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1 10.1016/j.bmcl.2012.01.082
290230 32610 37 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 220 1 1 3 2.5 CC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1412798 32610 37 None - 1 Rat 4.9 pIC50 = 4.9 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 220 1 1 3 2.5 CC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
290221 87252 33 None - 1 Rat 4.8 pIC50 = 4.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 282 2 1 3 3.8 N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL233000 87252 33 None - 1 Rat 4.8 pIC50 = 4.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 282 2 1 3 3.8 N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
684674 152553 24 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 3 3.7 N#Cc1c(NC(=O)Cc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL397167 152553 24 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 3 3.7 N#Cc1c(NC(=O)Cc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57402678 71200 0 None - 1 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 328 4 1 2 6.0 CSc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956413 71200 0 None - 1 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 328 4 1 2 6.0 CSc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
57399214 71231 0 None - 1 Rat 4.8 pIC50 = 4.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 322 2 1 3 3.9 N#Cc1c(NC(=O)C2Cc3ccccc3C2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956444 71231 0 None - 1 Rat 4.8 pIC50 = 4.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 322 2 1 3 3.9 N#Cc1c(NC(=O)C2Cc3ccccc3C2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57399211 71211 0 None - 1 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 332 3 1 1 6.4 CC(C)c1cc(C(C)(C)C)cc(-c2cccc3ccccc23)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956424 71211 0 None - 1 Rat 6.8 pIC50 = 6.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 332 3 1 1 6.4 CC(C)c1cc(C(C)(C)C)cc(-c2cccc3ccccc23)c1CO 10.1016/j.bmcl.2012.01.082
57390453 71218 1 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 260 2 1 3 3.2 N#Cc1c(NC(=O)C2CCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956431 71218 1 None - 1 Rat 5.8 pIC50 = 5.8 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 260 2 1 3 3.2 N#Cc1c(NC(=O)C2CCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
800118 71216 6 None - 1 Rat 5.7 pIC50 = 5.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 262 3 1 3 3.5 CC(C)CC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956429 71216 6 None - 1 Rat 5.7 pIC50 = 5.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 262 3 1 3 3.5 CC(C)CC(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
57395758 71227 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 352 3 1 4 4.9 N#Cc1c(NC(=O)Cc2cc3ccccc3s2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956440 71227 0 None - 1 Rat 5.7 pIC50 = 5.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 352 3 1 4 4.9 N#Cc1c(NC(=O)Cc2cc3ccccc3s2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57395679 71199 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956412 71199 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
57393989 71210 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(-c3ccccc3)c2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956423 71210 0 None - 1 Rat 6.7 pIC50 = 6.7 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(-c3ccccc3)c2)c1CO 10.1016/j.bmcl.2012.01.082
57397531 71209 0 None - 1 Rat 6.6 pIC50 = 6.6 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 1 5.6 Cc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956422 71209 0 None - 1 Rat 6.6 pIC50 = 6.6 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 1 5.6 Cc1cccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)c1 10.1016/j.bmcl.2012.01.082
694422 71217 30 None - 1 Rat 5.6 pIC50 = 5.6 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 246 2 1 3 2.8 N#Cc1c(NC(=O)C2CC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956430 71217 30 None - 1 Rat 5.6 pIC50 = 5.6 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 246 2 1 3 2.8 N#Cc1c(NC(=O)C2CC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57399210 71208 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 316 3 1 1 5.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(Cl)cc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956421 71208 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 316 3 1 1 5.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(Cl)cc2)c1CO 10.1016/j.bmcl.2012.01.082
767327 71220 35 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 310 4 1 3 4.1 N#Cc1c(NC(=O)CCc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956433 71220 35 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 310 4 1 3 4.1 N#Cc1c(NC(=O)CCc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57393988 71207 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 1 5.6 Cc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1 10.1016/j.bmcl.2012.01.082
CHEMBL1956420 71207 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 296 3 1 1 5.6 Cc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1 10.1016/j.bmcl.2012.01.082
57395754 71206 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 325 4 1 2 5.3 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(N(C)C)c2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956419 71206 0 None - 1 Rat 6.5 pIC50 = 6.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 325 4 1 2 5.3 CC(C)c1cc(C(C)(C)C)cc(-c2cccc(N(C)C)c2)c1CO 10.1016/j.bmcl.2012.01.082
57400888 71193 0 None - 1 Rat 5.5 pIC50 = 5.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccccc2-c2ccccc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956259 71193 0 None - 1 Rat 5.5 pIC50 = 5.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccccc2-c2ccccc2)c1CO 10.1016/j.bmcl.2012.01.082
729610 56435 12 None - 1 Rat 5.5 pIC50 = 5.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 248 2 1 3 3.1 CC(C)C(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1632048 56435 12 None - 1 Rat 5.5 pIC50 = 5.5 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 248 2 1 3 3.1 CC(C)C(=O)Nc1sc2c(c1C#N)CCCC2 10.1016/j.bmcl.2012.01.082
57400972 71228 0 None - 1 Rat 5.4 pIC50 = 5.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 338 3 1 4 3.8 N#Cc1c(NC(=O)CC2Cc3ccccc3O2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956441 71228 0 None - 1 Rat 5.4 pIC50 = 5.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 338 3 1 4 3.8 N#Cc1c(NC(=O)CC2Cc3ccccc3O2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57397476 71205 0 None - 1 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 282 3 1 1 5.3 CC(C)c1cc(C(C)(C)C)cc(-c2ccccc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956418 71205 0 None - 1 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 282 3 1 1 5.3 CC(C)c1cc(C(C)(C)C)cc(-c2ccccc2)c1CO 10.1016/j.bmcl.2012.01.082
4625719 71225 12 None - 1 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 340 5 1 4 4.1 COc1ccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)cc1 10.1016/j.bmcl.2012.01.082
CHEMBL1956438 71225 12 None - 1 Rat 6.4 pIC50 = 6.4 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 340 5 1 4 4.1 COc1ccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)cc1 10.1016/j.bmcl.2012.01.082
4578060 71219 10 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 274 2 1 3 3.6 N#Cc1c(NC(=O)C2CCCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956432 71219 10 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 274 2 1 3 3.6 N#Cc1c(NC(=O)C2CCCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
847353 151927 12 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 288 2 1 3 4.0 N#Cc1c(NC(=O)C2CCCCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL396627 151927 12 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 288 2 1 3 4.0 N#Cc1c(NC(=O)C2CCCCC2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
16644244 71223 8 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1ccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)cc1 10.1016/j.bmcl.2012.01.082
CHEMBL1956436 71223 8 None - 1 Rat 6.3 pIC50 = 6.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1ccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)cc1 10.1016/j.bmcl.2012.01.082
57393990 71229 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 335 3 2 3 4.2 N#Cc1c(NC(=O)Cc2cc3ccccc3[nH]2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956442 71229 0 None - 1 Rat 4.3 pIC50 = 4.3 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 335 3 2 3 4.2 N#Cc1c(NC(=O)Cc2cc3ccccc3[nH]2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
57392239 71224 0 None - 1 Rat 6.2 pIC50 = 6.2 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 340 5 1 4 4.1 COc1cccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956437 71224 0 None - 1 Rat 6.2 pIC50 = 6.2 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 340 5 1 4 4.1 COc1cccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)c1 10.1016/j.bmcl.2012.01.082
57390395 71204 0 None - 1 Rat 6.2 pIC50 = 6.2 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(-c3ccccc3)cc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956417 71204 0 None - 1 Rat 6.2 pIC50 = 6.2 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 358 4 1 1 6.9 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(-c3ccccc3)cc2)c1CO 10.1016/j.bmcl.2012.01.082
15015051 71203 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 300 3 1 1 5.4 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(F)cc2)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956416 71203 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 300 3 1 1 5.4 CC(C)c1cc(C(C)(C)C)cc(-c2ccc(F)cc2)c1CO 10.1016/j.bmcl.2012.01.082
57399213 71222 1 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1cccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)c1 10.1016/j.bmcl.2012.01.082
CHEMBL1956435 71222 1 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 324 4 1 3 4.4 Cc1cccc(CCC(=O)Nc2sc3c(c2C#N)CCCC3)c1 10.1016/j.bmcl.2012.01.082
57395757 71214 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 310 3 1 1 5.9 Cc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1C 10.1016/j.bmcl.2012.01.082
CHEMBL1956427 71214 0 None - 1 Rat 7.1 pIC50 = 7.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 310 3 1 1 5.9 Cc1ccc(-c2cc(C(C)(C)C)cc(C(C)C)c2CO)cc1C 10.1016/j.bmcl.2012.01.082
57400906 71202 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1ccccc1-c1cc(C(C)(C)C)cc(C(C)C)c1CO 10.1016/j.bmcl.2012.01.082
CHEMBL1956415 71202 0 None - 1 Rat 6.1 pIC50 = 6.1 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 2 5.3 COc1ccccc1-c1cc(C(C)(C)C)cc(C(C)C)c1CO 10.1016/j.bmcl.2012.01.082
775619 71232 16 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 4 3.5 N#Cc1c(NC(=O)COc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
CHEMBL1956445 71232 16 None - 1 Rat 5.0 pIC50 = 5.0 Functional
Antagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assayAntagonist activity at vasoactive intestinal peptide receptor 1 in rat RKE cells assessed as inhibition of VIP-induced intracellular cAMP accumulation incubated for 10 mins prior to VIP-stimulation measured after 30 mins by HTRF assay
ChEMBL 312 4 1 4 3.5 N#Cc1c(NC(=O)COc2ccccc2)sc2c1CCCC2 10.1016/j.bmcl.2012.01.082
2258 2991 0 None -15 4 Human 7.4 pEC50 = 7.4 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2278 328 0 None 4168 3 Human 7.6 pEC50 = 7.6 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16133238 2990 0 None -44 6 Human 7.6 pEC50 = 7.6 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2257 2990 0 None -44 6 Human 7.6 pEC50 = 7.6 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
44134520 2990 0 None -44 6 Human 7.6 pEC50 = 7.6 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
1152 3995 16 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16129679 3995 16 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
53395115 3995 16 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
91898389 3995 16 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
CHEMBL1981592 3995 16 None 1 8 Human 7.9 pEC50 = 7.9 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
1152 3995 16 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16129679 3995 16 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
53395115 3995 16 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
91898389 3995 16 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
CHEMBL1981592 3995 16 None 1 8 Human 10.0 pEC50 = 10 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2278 328 0 None 4168 3 Human 10.2 pEC50 = 10.2 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2259 3346 0 None -190 4 Human 6.0 pEC50 = 6 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
129887154 583 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
155817438 583 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
16214732 583 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
2269 583 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
2281 583 0 None -177 3 Human 7.0 pEC50 = 7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 11978642
2272 3078 0 None -30 3 Human 8.1 pEC50 = 8.1 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
1152 3995 16 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
16129679 3995 16 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
53395115 3995 16 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
91898389 3995 16 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
CHEMBL1981592 3995 16 None 1 8 Human 9.3 pEC50 = 9.3 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
2258 2991 0 None -15 4 Human 9.7 pEC50 = 9.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16133238 2990 0 None -44 6 Human 9.9 pEC50 = 9.9 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2257 2990 0 None -44 6 Human 9.9 pEC50 = 9.9 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
44134520 2990 0 None -44 6 Human 9.9 pEC50 = 9.9 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16133238 2990 0 None -44 6 Human 8.2 pEC50 = 8.2 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
2257 2990 0 None -44 6 Human 8.2 pEC50 = 8.2 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
44134520 2990 0 None -44 6 Human 8.2 pEC50 = 8.2 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
3842 2436 0 None -2 5 Human 8.3 pEC50 = 8.3 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
1152 3995 16 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
16129679 3995 16 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
53395115 3995 16 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
91898389 3995 16 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
CHEMBL1981592 3995 16 None 1 8 Human 8.5 pEC50 = 8.5 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
1152 3995 16 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
16129679 3995 16 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
53395115 3995 16 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
91898389 3995 16 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
CHEMBL1981592 3995 16 None 1 8 Human 8.9 pEC50 = 8.9 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
2278 328 0 None 4168 3 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
1152 3995 16 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
16129679 3995 16 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
53395115 3995 16 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
91898389 3995 16 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
CHEMBL1981592 3995 16 None 1 8 Human 9.4 pEC50 = 9.4 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
2272 3078 0 None -30 3 Human 5.5 pEC50 > 5.5 Functional
calcium influx in CHO cells stably expressing recombinant receptorcalcium influx in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2276 3345 0 None -316 2 Human 6.0 pEC50 > 6 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
2259 3346 0 None -190 4 Human 6.0 pEC50 > 6 Functional
stimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptorstimulation of cyclic AMP formation in CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
43708 217703 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
NoneNone
Drug Central 525 10 3 13 -0.7 CN(C)CCN1N=NN=C1SCC1=C(N2[C@H](SC1)[C@H](NC(=O)CC1=CSC(N)=N1)C2=O)C(O)=O None
131850923 3077 0 None -1 5 Human 8.7 pIC50 = 8.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
155817437 3077 0 None -1 5 Human 8.7 pIC50 = 8.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
16154651 3077 0 None -1 5 Human 8.7 pIC50 = 8.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
2268 3077 0 None -1 5 Human 8.7 pIC50 = 8.7 Functional
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 10570056
131850923 3077 0 None -1 5 Human 8.0 pIC50 = 8 Functional
inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptorinhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
155817437 3077 0 None -1 5 Human 8.0 pIC50 = 8 Functional
inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptorinhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16154651 3077 0 None -1 5 Human 8.0 pIC50 = 8 Functional
inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptorinhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2268 3077 0 None -1 5 Human 8.0 pIC50 = 8 Functional
inhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptorinhibition of calcium influx stimulated by 30nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
131850923 3077 0 None -1 5 Human 7.1 pIC50 = 7.1 Functional
inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptorinhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
155817437 3077 0 None -1 5 Human 7.1 pIC50 = 7.1 Functional
inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptorinhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
16154651 3077 0 None -1 5 Human 7.1 pIC50 = 7.1 Functional
inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptorinhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633
2268 3077 0 None -1 5 Human 7.1 pIC50 = 7.1 Functional
inhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptorinhibition of cyclic AMP formation stimulated by 0.3nM VIP in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 16930633




Ligands (move mouse cursor over ligand name to see structure) Receptor Assay information Chemical information
Sel. page Similar-
ity
Common
name
GPCRdb
ID
#Vendors

Reference
ligand
Fold
selectivity
# Tested
GPCRs
Species

p-value
(-log)
Activity
Type
Activity
Relation
Activity
Value
Assay
Type
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

CHEMBL524658 215614 0 None - 1 Human 10.4 pIC50 = 10.4 Binding
Displacement of [125I]PACAP1-27 from human recombinant PAC1 receptor expressed in CHO cells measured after 120 mins by scintillation counting methodDisplacement of [125I]PACAP1-27 from human recombinant PAC1 receptor expressed in CHO cells measured after 120 mins by scintillation counting method
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.bmc.2016.11.014
CHEMBL524658 215614 0 None - 1 Human 10.3 pIC50 = 10.3 Binding
Binding affinity to human VPAC1 receptor by radioligand displacement assayBinding affinity to human VPAC1 receptor by radioligand displacement assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(N)=O)C(C)C)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.bmc.2013.03.016
CHEMBL1893324 209060 24 None - 1 Human 10.0 pIC50 = 10.0 Binding
Displacement of [125I]VIP from human recombinant VIP1 receptor expressed in CHO cellsDisplacement of [125I]VIP from human recombinant VIP1 receptor expressed in CHO cells
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.bmc.2016.03.006
CHEMBL3884667 212417 0 None - 0 Human 10.0 pIC50 = 10.0 Binding
Displacement of [125I]VIP from human recombinant VPAC1 receptor expressed in CHO cells measured after 60 mins by scintillation counting methodDisplacement of [125I]VIP from human recombinant VPAC1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.bmc.2016.11.014
CHEMBL1893324 209060 24 None - 1 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to human VPAC1 receptor by radioligand displacement assayBinding affinity to human VPAC1 receptor by radioligand displacement assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.bmc.2013.03.016
CHEMBL1893324 209060 24 None - 1 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to human VPAC1 receptor by radioligand displacement assayBinding affinity to human VPAC1 receptor by radioligand displacement assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.ejmech.2013.01.044
72548703 161567 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]VIP from human recombinant VPAC1 receptor after 60 mins by scintillation counting analysisDisplacement of [125I]VIP from human recombinant VPAC1 receptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
CHEMBL4128926 161567 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]VIP from human recombinant VPAC1 receptor after 60 mins by scintillation counting analysisDisplacement of [125I]VIP from human recombinant VPAC1 receptor after 60 mins by scintillation counting analysis
ChEMBL 583 8 3 6 5.8 CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12 10.1016/j.bmcl.2018.03.093
127034614 136503 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3246 105 48 45 -10.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL3736230 136503 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3246 105 48 45 -10.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
127034614 136503 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3246 105 48 45 -10.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL3736230 136503 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3246 105 48 45 -10.8 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
2263 257 0 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cellsDisplacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm0609059
44566111 257 0 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cellsDisplacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm0609059
CHEMBL219499 257 0 None - 1 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cellsDisplacement of [125I]PACAP27 from human VPAC1 receptor expressed in CHO cells
ChEMBL None None None None 10.1021/jm0609059
CHEMBL507480 214335 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL4296687 213541 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of human VIP1 receptorInhibition of human VIP1 receptor
ChEMBL None None None CC[C@@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)O 10.1021/jm701575k
CHEMBL524852 215621 6 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
127035881 136485 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3264 105 48 45 -10.6 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccc(F)cc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL3736134 136485 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3264 105 48 45 -10.6 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccc(F)cc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
127035881 136485 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3264 105 48 45 -10.6 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccc(F)cc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL3736134 136485 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysisDisplacement of Ac-[125I]-PACAP27 from recombinant human VPAC1 expressed in CHO cells after 90 mins by gamma counting analysis
ChEMBL 3264 105 48 45 -10.6 CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccc(C#Cc2ccc(F)cc2)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)C(C)C)[C@@H](C)O 10.1016/j.ejmech.2015.09.017
CHEMBL1893324 209060 24 None - 1 Human 10.2 pKi = 10.2 Binding
Binding affinity to human VPAC1 receptor by radioligand displacement assayBinding affinity to human VPAC1 receptor by radioligand displacement assay
ChEMBL None None None CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc1c[nH]cn1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(N)=O 10.1016/j.ejmech.2013.01.044
1155 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
16129665 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3643 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
CHEMBL1201488 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
DB00021 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3842 2436 0 None - 0 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
1152 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
16129679 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
53395115 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
91898389 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
CHEMBL1981592 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3293 468 0 None - 0 Rat 9.0 pIC50 = 9 Binding
Inhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from CHO cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
1155 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
16129665 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3643 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
CHEMBL1201488 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
DB00021 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3293 468 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
1152 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
16129679 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
53395115 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
91898389 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
CHEMBL1981592 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
3842 2436 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptorInhibition of [125I]VIP binding in membranes from LoVo cells expressing recombinant receptor
Guide to Pharmacology None None None None 9437714
129887154 583 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
155817438 583 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
16214732 583 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
2269 583 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
2281 583 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
inhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-PACAP-27 binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11978642
2275 3113 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
1155 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16129665 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
3643 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
CHEMBL1201488 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
DB00021 3572 0 None -3162 2 Human 5.8 pIC50 = 5.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16132369 1918 0 None - 1 Human 6.0 pIC50 = 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2280 1918 0 None - 1 Human 6.0 pIC50 = 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
53230038 1918 0 None - 1 Human 6.0 pIC50 = 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2273 3109 0 None - 0 Human 6.0 pIC50 = 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2259 3346 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
1155 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16129665 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
3643 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
CHEMBL1201488 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
DB00021 3572 0 None - 2 Rat 6.5 pIC50 = 6.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2272 3078 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11068102
2259 3346 0 None - 0 Human 7.0 pIC50 = 7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9145428
2266 2894 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
3842 2436 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
16133238 2990 0 None 1 3 Human 7.8 pIC50 = 7.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
2257 2990 0 None 1 3 Human 7.8 pIC50 = 7.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
44134520 2990 0 None 1 3 Human 7.8 pIC50 = 7.8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
131850923 3077 0 None - 0 Rat 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9437716
155817437 3077 0 None - 0 Rat 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9437716
16154651 3077 0 None - 0 Rat 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9437716
2268 3077 0 None - 0 Rat 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9437716
1152 3995 16 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
16129679 3995 16 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
53395115 3995 16 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
91898389 3995 16 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
CHEMBL1981592 3995 16 None 5 4 Human 8.0 pIC50 = 8 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
16132369 1918 0 None - 1 Rat 8.1 pIC50 = 8.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2280 1918 0 None - 1 Rat 8.1 pIC50 = 8.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
53230038 1918 0 None - 1 Rat 8.1 pIC50 = 8.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2271 2895 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
16133238 2990 0 None 1 3 Human 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2257 2990 0 None 1 3 Human 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
44134520 2990 0 None 1 3 Human 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2273 3109 0 None - 0 Rat 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2275 3113 0 None - 0 Rat 8.5 pIC50 = 8.5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2271 2895 0 None - 0 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
1152 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
1152 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
1152 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
16129679 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
16129679 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16129679 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
53395115 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
53395115 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
53395115 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
91898389 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
91898389 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
91898389 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
CHEMBL1981592 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
CHEMBL1981592 3995 16 None 5 4 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
CHEMBL1981592 3995 16 None - 4 Rat 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9726637
16133238 2990 0 None - 3 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
2257 2990 0 None - 3 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
44134520 2990 0 None - 3 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
1152 3995 16 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
16129679 3995 16 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
53395115 3995 16 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
91898389 3995 16 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
CHEMBL1981592 3995 16 None - 4 Rat 9.0 pIC50 = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9928018
1152 3995 16 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
16129679 3995 16 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
53395115 3995 16 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
91898389 3995 16 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
CHEMBL1981592 3995 16 None 5 4 Human 9.3 pIC50 = 9.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10570056
131850923 3077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 10570056
131850923 3077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 9437716
155817437 3077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 10570056
155817437 3077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 9437716
16154651 3077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 10570056
16154651 3077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 9437716
2268 3077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 10570056
2268 3077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor, or from LoVo cells which endogenously express the receptor
Guide to Pharmacology None None None None 9437716
2259 3346 0 None - 0 Human 6.0 pIC50 > 6 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 11931347
53314964 216321 0 125I-VIP 1 3 Human 9.7 pKi = 9.7 Binding
NoneNone
PDSP KiDatabase 3325 113 51 48 -14.6 CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CNC=N4)N None
53314964 216321 0 125I-VIP 1 3 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 3325 113 51 48 -14.6 CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CNC=N4)N None
53314964 216321 0 125I-VIP 1 3 Human 8.8 pKi = 8.8 Binding
NoneNone
PDSP KiDatabase 3325 113 51 48 -14.6 CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC3=CC=CC=C3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC4=CNC=N4)N None
243 3202 91 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3052762 3202 91 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
3502 3202 91 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
CHEMBL117287 3202 91 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
DB06480 3202 91 125I-VIP -1096 34 Human 5.0 pKi = 5 Binding
NoneNone
PDSP KiDatabase 367 6 2 5 2.1 COCCCN1CCC(CC1)NC(=O)c1cc(Cl)c(c2c1OCC2)N None
1152 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
16129679 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
53395115 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
91898389 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
CHEMBL1981592 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in CHO cells stably expressing recombinant receptorcyclic AMP formation in CHO cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
1152 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
16129679 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
53395115 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
91898389 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
CHEMBL1981592 3995 16 None 5 4 Human 9.7 pKi = 9.7 Binding
cyclic AMP formation in HEK293 cells stably expressing recombinant receptorcyclic AMP formation in HEK293 cells stably expressing recombinant receptor
Guide to Pharmacology None None None None 8074647
1152 3995 16 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
16129679 3995 16 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
53395115 3995 16 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
91898389 3995 16 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
CHEMBL1981592 3995 16 None 5 4 Human 8.5 pKi = 8.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
2274 3111 0 None - 1 Human 5.7 pKi = 5.7 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16132353 1789 0 None - 1 Human 6.2 pKi = 6.2 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
2270 1789 0 None - 1 Human 6.2 pKi = 6.2 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16132369 1918 0 None - 1 Human 7.3 pKi = 7.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
2280 1918 0 None - 1 Human 7.3 pKi = 7.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
53230038 1918 0 None - 1 Human 7.3 pKi = 7.3 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
2278 328 0 None 316 2 Human 8.1 pKi = 8.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
2258 2991 0 None -2 3 Human 8.2 pKi = 8.2 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16133238 2990 0 None 1 3 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
2257 2990 0 None 1 3 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
44134520 2990 0 None 1 3 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
1152 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
1152 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16129679 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
16129679 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
53395115 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
53395115 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
91898389 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
91898389 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
CHEMBL1981592 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 10801840
CHEMBL1981592 3995 16 None 5 4 Human 9.0 pKi = 9 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
1152 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
16129679 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
53395115 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
91898389 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
CHEMBL1981592 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
1152 3995 16 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
16129679 3995 16 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
53395115 3995 16 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
91898389 3995 16 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
CHEMBL1981592 3995 16 None 5 4 Human 8.9 pKi = 8.9 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 9454823
1152 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
16129679 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
53395115 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
91898389 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
CHEMBL1981592 3995 16 None 5 4 Human 9.1 pKi = 9.1 Binding
inhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from COS cells transiently expressing the recombinant receptor
Guide to Pharmacology None None None None 8390245
1152 3995 16 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
16129679 3995 16 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
53395115 3995 16 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
91898389 3995 16 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
CHEMBL1981592 3995 16 None 5 4 Human 9.8 pKi = 9.8 Binding
inhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from HEK293 cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8074647
2276 3345 0 None -316 2 Human 5.5 pKi > 5.5 Binding
inhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 9152366
1155 3572 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
16129665 3572 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
3643 3572 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
CHEMBL1201488 3572 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009
DB00021 3572 0 None -3162 2 Human 5.0 pKi > 5 Binding
inhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptorinhibition of [125I]-VIP binding to membranes from CHO cells stably expressing the recombinant receptor
Guide to Pharmacology None None None None 8791009